Trial intelligence / Profile preview

INSTANT: Integrilin in Complex PCI

NCT00638976Phase 3Completed

Sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari
Start
Nov 2007
Primary completion
Feb 2010
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of eptifibatide in coronary artery disease (CAD), sponsored by Fondazione Evidence per Attività e Ricerche Cardiovascolari. Started Nov 2007; status: completed.

02

Drugs

eptifibatide
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00638976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00638976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call